|Year : 2020 | Volume
| Issue : 4 | Page : 323-329
Systematic review and meta-analysis of the association between C-746T and C-703T polymorphisms of the interleukin-5 gene and asthma
Raghdah Maytham Hameed1, Haidar Abdul Amir Najim Abood2, Mohanad Mohsin Ahmed3
1 Department of Immunology, Al-Sader Hospital, AL-Najaf, Iraq
2 Department of Pharmacology, University of Kerbala, Kerbala, Iraq
3 Department of Medical Microbiology, University of Kerbala, Kerbala, Iraq
|Date of Submission||23-Apr-2020|
|Date of Acceptance||02-May-2020|
|Date of Web Publication||30-Dec-2020|
Miss. Raghdah Maytham Hameed
Department of Immunology, Al-Sader Hospital, AL-Najaf
Source of Support: None, Conflict of Interest: None
Background: Asthma is a common disease with a complex risk architecture including both genetic and environmental factors. A number of studies have identified the association between interleukin (IL)-5 C-746T and C-703T polymorphisms and asthma risk, however, the results still remain inconclusive. The objective of the present study was to identify the effect of IL-5 polymorphisms in asthma susceptibility. Methods: PubMed and Google Scholar databases were searched. The odds ratio (OR) with its 95% confidence interval (CI) was employed to calculate the effect and strength of association in the random-effects model or fixed-effects model. Results: A total of 4 case–control and 2 cross-sectional studies were screened out, including 1499 asthma patients and 3766 controls. Two single-nucleotide polymorphisms of the IL-5 gene were identified. Our results detected a no significant association between IL-5 C-746T polymorphisms and asthma risk in the total population (CC genotype showed OR = 0.82, 95% CI = 0.67–1.00, P = 0.05, I2 = 0%; CT genotype showed OR = 0.94, 95% CI = 0.78–1.13, P = 0.50, I2 = 24%; and TT genotype showed OR = 0.85, 95% CI = 0.64–1.13, P = 0.27, I2 = 0%) while a significant association between IL-5 C-703T polymorphisms and asthma in children according to review results. Conclusion: The meta-analysis findings suggest a lack of direct association between the IL-5 C-746T polymorphism and asthma and found that C-703T polymorphisms of the IL-5 gene might contribute to asthma risk. Future well-designed case–control studies with a large population and more ethnicities are still needed to estimate the association.
Keywords: Asthma, interleukin-5, meta-analysis, single-nucleotide polymorphism
|How to cite this article:|
Hameed RM, Najim Abood HA, Ahmed MM. Systematic review and meta-analysis of the association between C-746T and C-703T polymorphisms of the interleukin-5 gene and asthma. Biomed Biotechnol Res J 2020;4:323-9
|How to cite this URL:|
Hameed RM, Najim Abood HA, Ahmed MM. Systematic review and meta-analysis of the association between C-746T and C-703T polymorphisms of the interleukin-5 gene and asthma. Biomed Biotechnol Res J [serial online] 2020 [cited 2021 Dec 3];4:323-9. Available from: https://www.bmbtrj.org/text.asp?2020/4/4/323/305646
| Introduction|| |
Asthma is the most common chronic lower respiratory tract and noncommunicable disease in children and adults throughout the world, characterized by inflammation which affects both proximal and distal airways.,,, Asthma typically presents with a history of respiratory symptoms such as wheezing, cough, shortness of breath, and chest tightness and is characterized by underlying chronic airway inflammation. Childhood asthma prevalence doubled from 1980 to 1995 and then increased more slowly from 2001 to 2010. It is a global health problem affecting around 300 million individuals of all ages, ethnic groups, and countries. It is estimated that around 250,000 people die prematurely each year as a result of asthma. Asthma is a highly prevalent chronic inflammatory disease of the airways, with differences in etiology, immunologic mechanisms, clinical presentation, pathogenesis, comorbidities, prognosis, and response to treatment, arising from not fully understood heterogenic gene–environment interactions. While environmental factors are important in the development of asthma, genetic factors could have a critical role in the expression of the disease, but the genetic background of bronchial asthma is complex, and it is likely that multiple genes contribute to its development both directly and through gene–gene interactions.,,,
Asthma is primarily an inflammatory disorder of the airways associated with T-helper type 2 (Th2), cell-dependent promotion of immunoglobulin (Ig) E production, and recruitment of mast cells and eosinophils. Allergen exposure results in the activation of numerous cells of the immune system, which include dendritic cells (DCs) and Th2 lymphocytes. DCs in the airway epithelium and submucosa detect inhaled allergens. DCs then migrate to the secondary lymphatic systems where they process and present antigens through major histocompatibility complex Class II to T and B lymphocytes, leading to the proliferation of Th1 or Th2 cell types and B lymphocytes produce IgE, which binds to high affinity FceRI on basophils and mast cells. In response to allergen presentation by airway DCs, T-helper lymphocytes of the adaptive immune system control many aspects of the disease through secretion of interleukin (IL)-4, IL-5, IL-13, IL-17, and IL-22, and these are counterbalanced by cytokines produced by T-regulatory cells.
IL-5 is an interdigitating homodimeric glycoprotein. IL-5 produced by both hematopoietic and nonhematopoietic cells including T-cells, granulocytes, and natural helper cells. It is a T-cell-derived cytokine involved in the pathogenesis of atopic diseases and plays important roles in the pathogenesis of asthma, hypereosinophilic syndromes, and eosinophil-dependent inflammatory diseases,,, it is believed to regulate the growth, differentiation, and activation of eosinophils. Further, acts on mature eosinophils to prolong maturation and survival and increased circulating eosinophil progenitors, suggesting a key role for systemic IL-5 in eosinophil mobilization. Moreover, IL-5 causes terminal maturation of the eosinophil by increasing CCR3 expression, potentially affecting CCR3-dependent chemotaxis by eosinophils and lymphocytes., In addition, overexpression of IL-5 significantly increases antibody levels in vivo and reported to act as a B-cell differentiation factor by stimulating activated B-cells to secrete antibody.,
IL-5 gene is located on chromosome 5. It is a potential candidate gene in the pathogenesis of asthma, which may play a role in blood eosinophilia associated with atopic dermatitis., Locus overexpression of IL-5 significantly increases eosinophil numbers and antibody levels in vivo. Conversely, mice lacking a functional gene for IL-5 or the IL-5 receptor-alpha chain (IL-5Rα) display a number of developmental and functional impairments in B-cell and eosinophil lineages., In addition, polymorphisms in the IL-5 genes may contribute to the susceptibility to atopic bronchial asthma and could determine the clinical course of the disease.
IL-5 gene is located on chromosome 5 within a cytokine gene cluster IL-4 and IL-13. Further, IL-5 gene, IL4, and IL13 may be regulated coordinately by long-range regulatory elements spread over 120 kilobases on chromosome 5q31.1. This gene encodes a cytokine that acts as a growth and differentiation factor for both B-cells and eosinophils. The association between the IL-5-746C/T and IL-5C703T polymorphisms and susceptibility of pediatric asthma has been investigated in previous study,,,,,,,,,,,, but the results are conflicting and inconclusive. In addition, there was no previous meta-analysis that assesses the association between IL-5-746C/T and IL-5C703T polymorphisms and risk of asthma. Further, this association has not been comprehensively reviewed, as previous review studies mainly focused on the association of other gene polymorphisms with the development of asthma. Therefore, we performed this study to precisely estimate the association between the IL-5-746C/T and IL-5C703T polymorphisms and susceptibility to asthma.
| Methods|| |
This is an integrative review of the literature, of a descriptive and exploratory character, based on the results of previous studies on the subject of IL-5-746C/T and IL-5C703T polymorphisms into asthma.
A comprehensive literature search was conducted using the electronic databases (PubMed and Google Scholar) using the keywords “Interleukin-5 polymorphism” and “Asthma” to search relevant articles published. The electronic searches were conducted during August 2019, and the search strategies were defined after the selection of the databases.
Inclusion and exclusion criteria
The inclusion criteria were as follows: (1) a case–control study, a cross-sectional study, and a cohort study; (2) the study must be evaluating the association between IL-5-746C/T and IL-5C703T polymorphisms and asthma susceptibility; and (3) the sample is composed of individuals of any age, of both sexes, with a diagnosis of asthma and independent of the time of diagnosis of the disease. The exclusion criteria were as follows: (1) conference papers, reports, comments, or review articles; (2) with duplicated data; (3) data cannot be extracted; (4) IL-5 polymorphisms in site other than 746C/T and IL-5C703T; and (5) the study evaluating the association between IL-5 polymorphisms and other diseases.
The quality of the studies was assessed using our inclusion and exclusion criteria [Figure 1]. Study quality was assessed by all the authors. The following data were retrieved: the name of the first author, publication year, ethnicity, country, mean age, genotyping methods and single-nucleotide polymorphisms, and a number of cases and controls.
Review Manager version 5.3 (Nordic Cochrane Centre, Cochrane Collaboration, Copenhagen, Sweden) was used to conduct the meta-analysis, sequential analysis, and publication bias assessment. The odds ratio (OR) with 95% confidence interval (CI) was employed to calculate the association between IL-5 C-764T polymorphisms and asthma risk. The pooled OR was determined using the Z-test, which considered as significant with P < 0.05. A test for heterogeneity was performed separately for three ORs, that is, homozygous dominant model (CC), heterozygous model (CT), and homozygous recessive model (TT). A test for heterogeneity was performed separately for three ORs, that is, homozygous dominant model (CC), heterozygous model (CT),and homozygous recessive model (TT) for the IL-5 C-764T gene. The between-study heterogeneity was assessed by the I2 test. The fixed-effects model was used when the P value of the I2 test was <25%. To estimate whether our results were substantially influenced by the presence of any individual study, a sensitivity analysis was performed by systematically omitting each included case–control study and recalculating the significance of the result. Checking Hardy–Weinberg equilibrium (HWE), HWE was checked in the patient and control groups using the Chi-square test. The funnel plot was used to examine the publication bias. In the absence of publication bias, it assumes that studies with high precision (large study effects) will be plotted near the average, and studies with low precision (small study effects) will be spread evenly on both sides of the average, creating a roughly funnel-shaped distribution. Deviation from this shape can indicate publication bias.
| Results|| |
Six studies were selected for the review and meta-analysis. All of them were conducted with the general objective of investigating relationships between IL-5-746C/T and IL-5C703T gene polymorphisms and asthma.
After filtering by availability and reading, consisting of reading the title, abstract, and keywords of each study, six articles were selected,,,,,, [Table 1]. The remainder were excluded from the analysis because they were not aligned with the subject of the review or with the inclusion criteria.
With relation to the types of study, all publications were the result of case–control, cross-sectional, and cohort study. Four of these were case–control studies. The samples used in the studies varied in terms of age group: one with adults, four with children, and one with mixed-age groups (children and adults). Half of the studies were conducted in the Caucasian and another half in the Asian. All studies used unique samples: a total of 1499 genotyped asthma cases and 3766 genotyped nonasthmatic controls were included in the meta-analysis. The characteristics and the genotype in each study are presented in [Table 1]. Deviation from HWE was detected to the asthmatic patients and controls in three studies,,, and only to the patients in one study, while the HWE result of Zhang et al. was taken from their original article. All studies suggested that the distribution of genotypes in the controls was consistent with HWE, as shown in [Table 2].
|Table 2: Distribution of interleukin.5 genotype among asthmatic patients and controls|
Click here to view
Funnel plot of IL-5 C-746T CC, CT, and TT genotypes for all studies included in the meta-analysis were presented in [Figure 2],[Figure 3], and [Figure 4] respectively. Standard error of the logarithm of the OR (SE(log[OR])) was plotted against the OR for each study. The symmetric, inverted funnel shape implies an absence of publication bias.
|Figure 2: Funnel plot of interleukin-5 C-746T polymorphism and asthma risk under the homozygous dominant model CC|
Click here to view
|Figure 3: Funnel plot of interleukin-5 C-746T polymorphism and asthma risk under the heterozygous model CT|
Click here to view
|Figure 4: Funnel plot of interleukin-5 C-746T polymorphism and asthma risk under the homozygous recessive model TT|
Click here to view
The result found that no significant difference was noted between the asthmatic patient and control groups in the genetic IL-5 c-764T polymorphism (CC genotype showed OR = 0.82, 95% CI = 0.67–1.00, P = 0.05; CT genotype showed OR = 0.94, 95% CI = 0.78–1.13, P = 0.50; and TT genotype showed OR = 0.85, 95% CI = 0.64–1.13, P = 0.27). As with the overall analysis, overt between-study heterogeneity (I2 = 0% and 24%) and publication bias were not detected, as presented in [Figure 5].
|Figure 5: Forest plots of the association between interleukin-5 C-746T polymorphism and asthma risk in the total population under the allelic model, (a) for homozygous dominant model (CC), (b) for heterozygous model (CT), and (c) for homozygous recessive model (TT)|
Click here to view
Guideline for interpretation of the I2 statistic results at figure 5: I2 = 0% – no heterogeneity, I2 = 25% – low heterogeneity, I2 = 50% – moderate heterogeneity, and I2 = 75% – high heterogeneity.
The foci of identification of the studies selected were investigations of associations between IL-5-746C/T and IL-5C703T polymorphisms involved in the asthmatic patients.
The relationship between IL-5-746C/T polymorphism and asthma was analyzed in four studies with samples of adults and children with different population profiles. One of them found that the association between asthma and IL-5-746C/T polymorphisms was not significant by comparing the occurrence of polymorphisms in asthmatic children and healthy children. The frequencies of the IL-5 CC homozygote 11.2% and CT heterozygote 41.7% in children with atopic asthma were not significantly different from the frequencies in healthy children (13.2% and 36.8%, respectively), whereas the study indicates that IL-5-746C/T polymorphisms may play a role in the pathogenesis of asthma, which found that the log serum total IgE concentration was significantly higher in asthmatic children with homozygous CC and heterozygous CT IL-5 mutant alleles (2.58–60.45 IU/mL) compared with those with wild-type TT alleles (2.45–60.44 IU/mL), P = 0.022. Further, atopic children with asthma with CC homozygote and CT heterozygote had lower forced expiratory flow at 25%–75% of forced vital capacity than those with the TT homozygote (74.2% ± 21.6% vs. 85.3% ± 24.5%) P = 0.002. A study by Kabesch et al. showed that the T allele at position-746 in the IL-5 gene was significantly protective for atopy in the International Study of Asthma and Allergies in Childhood-II population (P = 0.006). Furthermore, the risk for atopic asthma was decreased in carriers of the T allele (P = 0.036). Moreover, Zhang et al. failed to observe any association between polymorphisms of IL-5 at position-746C/T and susceptibility to asthma. Finally, another study demonstrated an association between the IL5 C-746T polymorphism and a decreased risk of developing asthma.
The other two studies with a different site of polymorphism (C-703T) analyzed links between asthma and IL-5 gene polymorphism. A study by Freidin et al. is the first evidence of an association between the IL-5 C-703T gene polymorphism and bronchial asthma, which found that analysis of the asthmatic patients and their relatives from Tomsk by the use of transmission/disequilibrium test revealed the presence of a statistically significant association between the C-703 IL5 allele and asthma (P = 0.005). In addition, this finding characterizes the polymorphisms examined as race specific. It can be hypothesized that the C-703T substitutions in the IL5 genes appeared long before the subdivision of humankind into the main races. Later processes of racial divergence resulted in the accumulation of different gene variants in the Caucasoids and Mongoloids. High heterozygosity observed for the C-703T polymorphism in all populations examined, which was close to the maximum for a biallelic marker, confirmed the possible ancient origin of these gene variants. Another study tested suggest that asthma in children is associated with TT genotype of IL-5 C-703T polymorphism. The frequency of genotype TT recorded OR = 2.026 with CI between 0.947 and 4.335 under 95%; it showed a statistically significant difference (P = 0.045) according to Fisher's exact test.
| Discussion|| |
We believe this is the first meta-analysis to investigate the association between IL-5 C-746T and C-703T polymorphisms and susceptibility to asthma. On the basis of three case–control studies and one cross-sectional and cohort study involving 1198 asthma cases and 3681 controls, the present meta-analysis did not find a significant association between the IL-5 C-746T polymorphism and asthma. In spite of between-study heterogeneity was not significant. On the other hand, the review of two other studies, has revealed the presence of a statistically significant association between the C-703T IL-5 polymorphism and developing asthma in children.
Certain limitations to this review and meta-analysis need to be taken into consideration when interpreting the findings. First, there was only one case–control study that investigated the association of IL-5 C-703T polymorphisms with pediatric asthma risk in the Asian. Further, there was no case–control study that investigated the association of IL-5 C-703T polymorphisms with pediatric asthma risk in the Caucasian. Therefore, more studies with larger sample sizes are needed to investigate the association of IL-5 C-703T among asthmatic children at the Asian and Caucasian. Second, because the number of included studies was insufficient and small studies with negative results are less likely to publish, hence the possibility of publication bias cannot be completely ruled out, even though the Egger's test and funnel plots did not show evidence of publication bias in this meta-analysis. Third, the control group for one study included in this meta-analysis was not in HWE. Fourth, the asthma phenotype was often not fully specified, details of asthma diagnoses were often scanty, and lack of evaluation of the effects of gene to gene and gene to environment interactions during pediatric asthma development. Without sufficient information in individual studies, the condition labeled as asthma in this meta-analysis is likely to be heterogeneous and may be contributing to the inconsistency of results.
| Conclusions|| |
This may be the first systematic and comprehensive meta-analysis of C-764T and C-703T polymorphisms in IL-5 and asthma. The results in this meta-analysis suggest that IL-5 C-746T polymorphisms are not associated with increased asthma risk, whereas IL-5 C-703T polymorphisms are associated with asthma in children. Further studies with large sample sizes were needed to confirm our findings.
The authors are grateful to the staff of the Karbala Teaching Hospital for children, Karbala University, Iraq, for their great help throughout this work.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Beasley R, Semprini A, Mitchell EA. Risk factors for asthma: Is prevention possible? Lancet 2015;386:1075-85.
Fu LS, Tsai MC. Asthma exacerbation in children: A practical review. Pediatr Neonatol 2014;55:83-91.
Papi A, Brightling C, Pedersen SE, Reddel HK. Asthma. Lancet 2018;391:783-800.
Perez T, Chanez P, Dusser D, Devillier P. Small airway impairment in moderate to severe asthmatics without significant proximal airway obstruction. Respir Med 2013;107:1667-74.
Wu AC, Li L, Fung V, Kharbanda EO, Larkin EK, Butler MG, et al
. Mismatching among guidelines, providers, and parents on controller medication use in children with asthma. J Allergy Clin Immunol Pract 2016;4:910-6.
Akinbami LJ, Simon AE, Rossen LM. Changing trends in asthma prevalence among children. Pediatrics 2016;137:e20152354.
Bousquet J, Mantzouranis E, Cruz AA, Aït-Khaled N, Baena-Cagnani CE, Bleecker ER, et al
. Uniform definition of asthma severity, control, and exacerbations: Document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol 2010;126:926-38.
Mims JW. Asthma: Definitions and Pathophysiology. Int Forum Allergy Rhinol 2015;5 Suppl 1:S2-6.
Brusselle G, Bracke K. Targeting immune pathways for therapy in asthma and chronic obstructive pulmonary disease. Ann Am Thorac Soc 2014;11 Suppl 5:S322-8.
Mahdaviani SA, Rezaei N, Moradi B, Dorkhosh S, Amirzargar AA, Movahedi M. Proinflammatory cytokine gene polymorphisms among Iranian patients with asthma. J Clin Immunol 2009;29:57-62.
Babusikova E, Jurecekova J, Jesenak M, Evinova A. Association of gene polymorphisms in interleukin 6 in infantile bronchial asthma. Arch Bronconeumol 2017;53:381-6.
Holgate ST. Innate and adaptive immune responses in asthma. Nat Med 2012;18:673-83.
Buc M, Dzurilla M, Vrlik M, Bucova M. Immunopathogenesis of bronchial asthma. Arch Immunol Ther Exp (Warsz) 2009;57:331-44.
Holgate ST, Arshad HS, Roberts GC, Howarth PH, Thurner P, Davies DE. A new look at the pathogenesis of asthma. Clin Sci (Lond) 2009;118:439-50.
Bharadwaj AS, Bewtra AK, Agrawal DK. Dendritic cells in allergic airway inflammation. Can J Physiol Pharmacol 2007;85:686-99.
Lambrecht BN, Hammad H. Asthma: The importance of dysregulated barrier immunity. Eur J Immunol 2013;43:3125-37.
Takatsu K, Kouro T, Nagai Y. Interleukin 5 in the link between the innate and acquired immune response. Adv Immunol 2009;101:191-236.
Takatsu K. Interleukin-5 and IL-5 receptor in health and diseases. Proc Jpn Acad Ser B Phys Biol Sci 2011;87:463-85.
Karlen S, de Boer ML, Lipscombe RJ, Lutz W, Mordvinov VA, Sanderson CJ. Biological and molecular characteristics of interleukin-5 and its receptor. Int Rev Immunol 1998;16:227-47.
Kouro T, Takatsu K. IL-5- and eosinophil-mediated inflammation: From discovery to therapy. Int Immunol 2009;21:1303-9.
Matthaei KI, Foster P, Young IG. The role of interleukin-5 (IL-5) in vivo
: Studies with IL-5 deficient mice. Mem Inst Oswaldo Cruz 1997;92 Suppl 2:63-8.
Takatsu K. Role of interleukin-5 in immune regulation and inflammation. Nihon Rinsho 2004;62:1941-51.
Stirling RG, van Rensen EL, Barnes PJ, Chung KF. Interleukin-5 induces CD34(+) eosinophil progenitor mobilization and eosinophil CCR3 expression in asthma. Am J Respir Crit Care Med 2001;164:1403-9.
Randall TD, Lund FE, Brewer JW, Aldridge C, Wall R, Corley RB. Interleukin-5 (IL-5) and IL-6 define two molecularly distinct pathways of B-cell differentiation. Mol Cell Biol 1993;13:3929-36.
Kotsimbos AT, Hamid Q. IL-5 and IL-5 receptor in asthma. Mem Inst Oswaldo Cruz 1997;92 Suppl 2:75-91.
Pereira E, Goldblatt J, Rye P, Sanderson C, Le Souëf P. Mutation analysis of interleukin-5 in an asthmatic cohort. Hum Mutat 1998;11:51-4.
Yamamoto N, Sugiura H, Tanaka K, Uehara M. Heterogeneity of interleukin 5 genetic background in atopic dermatitis patients: Significant difference between those with blood eosinophilia and normal eosinophil levels. J Dermatol Sci 2003;33:121-6.
Boulay JL, Paul WE. The interleukin-4 family of lymphokines. Curr Opin Immunol 1992;4:294-8.
Kabesch M, Depner M, Dahmen I, Weiland SK, Vogelberg C, Niggemann B, et al
. Polymorphisms in eosinophil pathway genes, asthma and atopy. Allergy 2007;62:423-8.
Hong SJ, Lee SY, Kim HB, Kim JH, Kim BS, Choi SO, et al
. IL-5 and thromboxane A2 receptor gene polymorphisms are associated with decreased pulmonary function in Korean children with atopic asthma. J Allergy Clin Immunol 2005;115:758-63.
Llanes E, Quiralte J, López E, Sastre B, Chacártegui M, del Pozo V, et al
. Analysis of polymorphisms in olive pollen allergy: IL13, IL4RA, IL5 and ADRB2 genes. Int Arch Allergy Immunol 2009;148:228-38.
Namkung JH, Lee JE, Kim E, Cho HJ, Kim S, Shin ES, et al
. IL-5 and IL-5 receptor alpha polymorphisms are associated with atopic dermatitis in Koreans. Allergy 2007;62:934-42.
Freidin MB, Kobyakova OS, Ogorodova LM, Puzyrev VP. Association of polymorphisms in the human IL4 and IL5 genes with atopic bronchial asthma and severity of the disease. Int J Genomics 2003;4:346-50.
Zhang H, Zhang Q, Wang L, Chen H, Li Y, Cui T, et al
. Association of IL4R gene polymorphisms with asthma in Chinese populations. Hum Mutat 2007;28:1046.
Rosenwasser LJ, Klemm DJ, Dresback JK, Inamura H, Mascali JJ, Klinnert M, et al
. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy 1995;25 Suppl 2:74-8.
Freidin MB, Puzyrev VP, Ogorodova LM, Kobiakova OS, Kulmanakova IM. Polymorphism of interleukins and interleukin receptor genes: Population distribution and association with atopic bronchial asthma. Genetika 2002;38:1710-8.
Hameed R, Ahmed M, Abood H. Specific IL-5 SNP is associated with high serum IL-5 levels and higher eosinophil counts among Iraqi asthmatic children. Biomed Biotechnol Res J BBRJ 2019;3:156-61.
Rioux JD, Stone VA, Daly MJ, Cargill M, Green T, Nguyen H, et al
. Familial eosinophilia maps to the cytokine gene cluster on human chromosomal region 5q31-q33. Am J Hum Genet 1998;63:1086-94.
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5]
[Table 1], [Table 2]